Expression of some cell adhesion molecules, such as ICAM-1 and LFA-3, is dysregulated in GBM compared with normal brain tissue and can serve as a novel marker for brain tumor detection and perhaps therapy [38, 39]. This evidence concerns the gene CD58 and brain neoplasm.